Novartis Halts Zantac Distribution, Citing Impurities
A unit of Swiss drug maker Novartis AG announced Wednesday that it's halting distribution of its versions of heartburn medication Ranitidine, more commonly known as Zantac, because of contaminants found in...To view the full article, register now.
Already a subscriber? Click here to view full article